Review of diagnostic, prognostic, and predictive biomarkers in melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of diagnostic, prognostic, and predictive biomarkers in melanoma
Authors
Keywords
Diagnostic, Prognostic, Predictive, Biomarker, Melanoma
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-02
DOI
10.1007/s10585-018-9892-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
- (2018) Jonathan S. Zager et al. BMC CANCER
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
- (2017) Eddy C. Hsueh et al. Journal of Hematology & Oncology
- Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification
- (2017) Laura K. Ferris et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
- (2017) Mark B. Faries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma
- (2016) Ievgenia Pastushenko et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Is a Wider Margin (2 cm vs. 1 cm) for a 1.01–2.0 mm Melanoma Necessary?
- (2016) Matthew P. Doepker et al. ANNALS OF SURGICAL ONCOLOGY
- Critical Assessment of Clinical Prognostic Tools in Melanoma
- (2016) Alyson L. Mahar et al. ANNALS OF SURGICAL ONCOLOGY
- The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients
- (2016) S. Damude et al. EJSO
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
- (2016) Ulrike Leiter et al. LANCET ONCOLOGY
- Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions
- (2016) Eugen C Minca et al. MODERN PATHOLOGY
- Metastatic pathways in patients with cutaneous melanoma
- (2016) Nikki R. Adler et al. Pigment Cell & Melanoma Research
- Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
- (2016) D. B. Johnson et al. Cancer Immunology Research
- Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
- (2015) P. Gerami et al. CLINICAL CANCER RESEARCH
- Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma
- (2015) Loren E. Clarke et al. JOURNAL OF CUTANEOUS PATHOLOGY
- More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
- (2015) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
- (2015) Pedram Gerami et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cutaneous Malignant Melanoma
- (2014) Ossama Abbas et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ambiguous Melanocytic Tumors in a Tertiary Referral Center
- (2013) Michael T. Tetzlaff et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
- (2013) Dale Han et al. JOURNAL OF CLINICAL ONCOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms
- (2012) Pedram Gerami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
- (2012) Björn Nodin et al. Diagnostic Pathology
- Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients
- (2012) K.P. Wevers et al. EJSO
- Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma
- (2012) Patricia S Nielsen et al. MODERN PATHOLOGY
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
- (2011) Augustinus P.T. van der Ploeg et al. JOURNAL OF CLINICAL ONCOLOGY
- D2-40 lymphatic marker for detecting lymphatic invasion in thin to intermediate thickness melanomas: Association with sentinel lymph node status and prognostic value—A retrospective case study
- (2011) Laurel E. Fohn et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Atypical Spitzoid melanocytic tumors: A morphological, mutational, and FISH analysis
- (2011) Daniela Massi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial
- (2011) Peter Gillgren et al. LANCET
- Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
- (2011) S.-J. Schramm et al. MOLECULAR CANCER THERAPEUTICS
- Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma
- (2010) MAJ Scott R. Dalton et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases
- (2010) Beatrice Vergier et al. MODERN PATHOLOGY
- Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up
- (2010) Timo Gaiser et al. MODERN PATHOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Role for RGS1 in Melanoma Progression
- (2009) Javier Rangel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi
- (2009) Pedram Gerami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization
- (2009) Pedram Pouryazdanparast et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma
- (2009) Pedram Gerami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
- (2009) M. Kashani-Sabet et al. CLINICAL CANCER RESEARCH
- Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
- (2009) Bonnie E. Gould Rothberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
- (2009) Bonnie E. Gould Rothberg et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search